STOCK TITAN

Agilent Increases Cash Dividend to 19.4 Cents Per Share

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

SANTA CLARA, Calif.--()--Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 19.4 cents per share of common stock. The dividend reflects an 8% increase over the previous quarter.

The dividend will be paid on Jan. 27, 2021 to all shareholders of record as of the close of business on Jan. 5, 2021.

The timing and amounts of future dividends are subject to determination and approval by Agilent’s board.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company’s dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties are detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2020. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

Contacts

INVESTOR CONTACT:
Ankur Dhingra
+1 408 345 8948
ankur_dhingra@agilent.com

MEDIA CONTACT:
Tom Beermann
+1 408 553 2914
tom.beermann@agilent.com

Agilent Technologies Inc.

NYSE:A

A Rankings

A Latest News

A Stock Data

Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Medical Specialties, Professional, Scientific, and Technical Services, Testing Laboratories
US
Santa Clara

About A

analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.